作者: Claudio Zavaglia , Andrea Mancuso , Antonella Foschi , Antonio Rampoldi
DOI: 10.3978/J.ISSN.2304-3881.2013.05.02
关键词:
摘要: Hepatocellular Carcinoma (HCC) is the leading cause of death in patients with cirrhosis (1). Despite recent advances early detection programs and diffusion surveillance protocols cirrhosis, only 30% to 40% are diagnosed at an stage can benefit from radical therapies